Fe-HCOF-PEG2000 as a Hypoxia-Tolerant Photosensitizer to Trigger Ferroptosis and Enhance ROS-Based Cancer Therapy
To our knowledge, Fe-HCOF-PEG<sup>2000</sup> is the leading combination of type I/II PDT and ferroptosis. The strong antitumor effects of this nanomaterial suggest prospects for clinical translation as a tumor nanotherapy drug.
Authors
- Hui Peng (ORCID: https://orcid.org/0000-0002-2777-0588)
- Zhonglan Hu
- Jia Mai (ORCID: https://orcid.org/0009-0001-4677-8999)
- Qian Jiang (ORCID: https://orcid.org/0000-0002-8504-7857)
- Chunbo Zhuang
- Qi Wang (ORCID: https://orcid.org/0000-0002-3210-7895)
- Li Zhang (ORCID: https://orcid.org/0000-0001-9203-2250)
- Zhuo Yu (ORCID: https://orcid.org/0000-0002-6431-7002)
- Ting Sun (ORCID: https://orcid.org/0000-0002-4200-9551)
- Wenhao Mao
- Xinyan Wang (ORCID: https://orcid.org/0000-0001-5428-4916)
- Zhiyuan Wang (ORCID: https://orcid.org/0009-0004-1401-4654)
Institutions
- Sichuan University (CN)
- Zhengzhou University (CN)
- West China Second University Hospital of Sichuan University (CN)
- Yangtze Optical Electronic (China) (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2024-10-01
- DOI
- https://doi.org/10.2147/ijn.s479848
- Citations
- 6
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 1.11